Search research articles
Contact Us
Filters
Showing results (181-190 of 288) with videos related to
Page
of 29
Sort By:
Blood Advances
|
January 25, 2018
Factor XI contributes to myocardial ischemia-reperfusion injury in mice
Christina U Lorentz, Norah G Verbout, Zhiping Cao, et al.
Cancer Research
|
December 5, 2000
Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: a phase II trial
J Nemunaitis, I Ganly, F Khuri, et al.
American Journal of Physiology. Cell Physiology
|
January 20, 2021
Role of platelets in regulating activated coagulation factor XI activity
Stéphanie E Reitsma, Jiaqing Pang, Vikram Raghunathan, et al.
Cellular and Molecular Bioengineering
|
July 17, 2023
Correction: Innovation and Entrepreneurship in Promotion and Tenure in Biomedical Engineering
Tia C L Kohs, Samuel N Clarin, Rich G Carter, et al.
Translational Stroke Research
|
May 2, 2013
Inhibition of Factor XII-Mediated Activation of Factor XI Provides Protection Against Experimental Acute Ischemic Stroke in Mice
Philberta Y Leung, Sawan Hurst, Michelle A Berny-Lang, et al.
Journal of Thrombosis and Thrombolysis
|
December 14, 2023
Predictors of thrombosis during VV ECMO: an analysis of 9809 patients from the ELSO registry
Tia C L Kohs, Benjamin R Weeder, Boris I Chobrutskiy, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
June 27, 2019
Endothelial PAI-1 (Plasminogen Activator Inhibitor-1) Blocks the Intrinsic Pathway of Coagulation, Inducing the Clearance and Degradation of FXIa (Activated Factor XI)
Cristina Puy, Anh T P Ngo, Jiaqing Pang, et al.
Artificial Organs
|
June 18, 2024
The development, use, and challenges of electromechanical tissue stimulation systems
Jie Hu, William Anderson, Emily Hayes, et al.
Stroke
|
April 23, 2011
Thrombin mutant W215A/E217A treatment improves neurological outcome and reduces cerebral infarct size in a mouse model of ischemic stroke
Michelle A Berny-Lang, Sawan Hurst, Erik I Tucker, et al.
Molecular Pharmacology
|
October 24, 2012
The anticancer ruthenium complex KP1019 induces DNA damage, leading to cell cycle delay and cell death in Saccharomyces cerevisiae
Shannon K Stevens, Amy P Strehle, Rebecca L Miller, et al.
Page
of 29
Search research articles
Search
Showing results (181-190 of 288) with videos related to
Sort By:
Page
of 29
Blood Advances
|
January 25, 2018
Factor XI contributes to myocardial ischemia-reperfusion injury in mice
Christina U Lorentz, Norah G Verbout, Zhiping Cao, et al.
Cancer Research
|
December 5, 2000
Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: a phase II trial
J Nemunaitis, I Ganly, F Khuri, et al.
American Journal of Physiology. Cell Physiology
|
January 20, 2021
Role of platelets in regulating activated coagulation factor XI activity
Stéphanie E Reitsma, Jiaqing Pang, Vikram Raghunathan, et al.
Cellular and Molecular Bioengineering
|
July 17, 2023
Correction: Innovation and Entrepreneurship in Promotion and Tenure in Biomedical Engineering
Tia C L Kohs, Samuel N Clarin, Rich G Carter, et al.
Translational Stroke Research
|
May 2, 2013
Inhibition of Factor XII-Mediated Activation of Factor XI Provides Protection Against Experimental Acute Ischemic Stroke in Mice
Philberta Y Leung, Sawan Hurst, Michelle A Berny-Lang, et al.
Journal of Thrombosis and Thrombolysis
|
December 14, 2023
Predictors of thrombosis during VV ECMO: an analysis of 9809 patients from the ELSO registry
Tia C L Kohs, Benjamin R Weeder, Boris I Chobrutskiy, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
June 27, 2019
Endothelial PAI-1 (Plasminogen Activator Inhibitor-1) Blocks the Intrinsic Pathway of Coagulation, Inducing the Clearance and Degradation of FXIa (Activated Factor XI)
Cristina Puy, Anh T P Ngo, Jiaqing Pang, et al.
Artificial Organs
|
June 18, 2024
The development, use, and challenges of electromechanical tissue stimulation systems
Jie Hu, William Anderson, Emily Hayes, et al.
Stroke
|
April 23, 2011
Thrombin mutant W215A/E217A treatment improves neurological outcome and reduces cerebral infarct size in a mouse model of ischemic stroke
Michelle A Berny-Lang, Sawan Hurst, Erik I Tucker, et al.
Molecular Pharmacology
|
October 24, 2012
The anticancer ruthenium complex KP1019 induces DNA damage, leading to cell cycle delay and cell death in Saccharomyces cerevisiae
Shannon K Stevens, Amy P Strehle, Rebecca L Miller, et al.
Page
of 29